CENTURION ILAC SAN VE TIC A.S.
Company Profile:
Company Type: Manufacturer (Factory)
Company Introduction:
Centurion Ilac Sanayi ve Ticaret A.S. is a reputable Turkish pharmaceutical company dedicated to the research, development, manufacturing, and marketing of a diverse portfolio of pharmaceutical products. The company operates its own state-of-the-art production facilities, underscoring its identity as a manufacturer. Centurion Ilac is committed to upholding high quality standards and regulatory compliance, ensuring the safety and efficacy of its medications. It plays a significant role in the healthcare sector by providing essential pharmaceutical solutions across various therapeutic areas, serving both domestic and international markets.
Enterprise Products
CENTURION ILAC SAN VE TIC A.S. produces or sells pharmaceutical products, primarily focusing on oncology, hematology, and rare diseases. Their product portfolio includes various specialized drugs.
Oncology Products:
Abiraterone Acetate
Acalabrutinib
Afatinib
Alectinib
Apalutamide
Bendamustine Hydrochloride
Bosutinib
Cabazitaxel
Cabozantinib
Ceritinib
Dabrafenib
Dacomitinib
Darolutamide
Dasatinib
Enzalutamide
Erlotinib
Everolimus
Exemestane
Gefitinib
Ibrutinib
Imatinib Mesylate
Lapatinib Ditosylate
Lenalidomide
Letrozole
Lorlatinib
Nilotinib
Nintedanib
Olaparib
Osimertinib
Palbociclib
Pazopanib Hydrochloride
Pomalidomide
Pralsetinib
Regorafenib
Ruxolitinib
Sunitinib Malate
Trametinib
Venetoclax
Zoledronic Acid
Hematology Products:
Ibrutinib
Imatinib Mesylate
Lenalidomide
Nilotinib
Pomalidomide
Ruxolitinib
Venetoclax
Dasatinib
Rare Diseases / Orphan Drugs:
Their focus also extends to drugs for rare diseases, many of which overlap with their oncology and hematology portfolio.
Business Registration Information:
Manager:
Phone:
E-mail:
info@centurionilac.com.tr
Official Website:
Address:
Organize Sanayi Bolgesi 1. Kisim 8. Cadde No:10, 07190 Dosemealti / Antalya / TURKEY
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.